CeriBell Stock (NASDAQ:CBLL)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$11.15

52W Range

$10.01 - $32.75

50D Avg

$21.27

200D Avg

$24.13

Market Cap

$538.03M

Avg Vol (3M)

$238.38K

Beta

1.74

Div Yield

-

CBLL Company Profile


CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

281

IPO Date

-

Website

CBLL Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24
Subscription$15.37M
Product$50.08M

Fiscal year ends in Dec 23 | Currency in USD

CBLL Financial Summary


Dec 23Dec 22
Revenue$45.23M$25.92M
Operating Income$-30.04M$-36.02M
Net Income$-29.46M$-37.16M
EBITDA$-26.51M$-35.06M
Basic EPS$-1.27$-1.59
Diluted EPS$-1.27$-1.59

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Mar 03, 25 | 4:30 PM